Comparing Disaboom (OTCMKTS:MEDH) and Pacific Biosciences of California (NASDAQ:PACB)

Pacific Biosciences of California (NASDAQ:PACB) and Disaboom (OTCMKTS:MEDH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Profitability

This table compares Pacific Biosciences of California and Disaboom’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pacific Biosciences of California	-325.02%	-101.49%	-18.83%
Disaboom	5.91%	N/A	N/A

Analyst Recommendations

This is a summary of current ratings for Pacific Biosciences of California and Disaboom, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacific Biosciences of California	1	3	3	0	2.29
Disaboom	0	0	0	0	0.00

Pacific Biosciences of California currently has a consensus target price of $2.08, suggesting a potential downside of 19.72%. Given Pacific Biosciences of California’s stronger consensus rating and higher possible upside, equities analysts plainly believe Pacific Biosciences of California is more favorable than Disaboom.

Earnings & Valuation

This table compares Pacific Biosciences of California and Disaboom”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacific Biosciences of California	$154.58 million	5.07	-$309.85 million	($2.20)	-1.18
Disaboom	$890,000.00	0.54	-$170,000.00	N/A	N/A

Disaboom has lower revenue, but higher earnings than Pacific Biosciences of California.

Volatility & Risk

Pacific Biosciences of California has a beta of 2.2, suggesting that its stock price is 120% more volatile than the S&P 500. Comparatively, Disaboom has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500.

Summary

Pacific Biosciences of California beats Disaboom on 6 of the 10 factors compared between the two stocks.

About Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

About Disaboom

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.